Basic guides
This Q&A explores the use of anti -obesity drugs during menopause, including the role of health coaches and exercise professionals in supporting their customers on this journey. After explaining how these medicines work, we explore the relationship between menopause and metabolism, as well as the importance of training during menopause. For women receiving AOM, the goal should be to maintain muscles and consume several protein foods and nutrients for fuel Life and activity.
Read below for experts on how to help your customers who go through menopause and take Aoms to browse this experience and achieve long -term health.
|
is the clinical manager at known Health, a healthcare body focused on the patient. With over 30 years of experience, he supports clinical doctors in the treatment of patients through personal and digital advice. Internationally Recognized expert on nutrition, metabolism and suitability, Adair is a sought -after speaker and media resource that appears on CNN and Discovery TV’s “FINAL GOAL”. Adair is also a member of ACE. |
How do AMS) supported drugs in menopause and what do exercise professionals should know about their effectiveness?
First, let’s see how menopause can lead to weight gain and then explore how Aoms could help when properly used.
Changes in hormones, especially a decline in estrogen, can affect the way the body stores fat and leads to weight or fat profit. Age -related muscle loss plays a key role in the natural decrease in metabolic rate (because the muscle is a more metabolic active tissue than fat). This means that the body burns less calories as the muscle is replaced by adipose tissue. If activity levels also decrease, calorie costs fall and weight gain may follow, unless eating habits are adapted.
In addition, research explores the way menopause can also affect signs of hunger and fullness, which could maintain the weight of one’s even more provocative. Sleep, anxiety and other psychosocial factors can also play a role, making maintaining a healthy weight even more complicated.
So how can Aoms-Special GLP-1-Drinks develop women in menopause? In the same way they do for others who meet the criteria for these drugs, reducing appetite, slowing down the digestion and signaling the brain to feel more fuller.
As more women use Aoms to manage appetite and cravings during menopause, how can health coaches and professionals practice professionals to adapt their support strategies while remaining in their scope?
The first research on GLP-1 medicines have mainly focused on how to help people eat less, but scientists are now exploring how these medicines affect food’s desires and preferences.
For example, in Vima 5 testing, people receiving semiaglitis (GLP-1 medication) reported fewer efforts for dairy and starchy foods, less desire for savory or spicy foods and better control of their eating habits. These findings indicate that weight loss in GLP-1s can be affected by changes in food choices, not just reducing intake. Research also investigates if GLP-1 medicines could help reduce other types of desires, such as those observed in alcohol use disorder. In a trial published in Jama’s psychiatry this year, over nine weeks of treatment, people who received semi -pollid drank less alcohol compared to those who received placebo. They also reported fewer cravings for alcohol. For those who smoke, Semaglutide also helped reduce how many cigarettes they smoke a day.
It is an exciting and emerging field of research and need future studies to help us better understand these results. Meantime, Exercise professionals can continue to guide customers towards dense nutrients, just as always.
How important is it to draw strength for women in AOM during menopause to maintain muscles and promote fat loss?
When food intake is reduced, with or without drugs, the body does not only burn fat. It will also collapse valuable muscles and other lean tissues.
Emerging research begins to consider the strong role exercise that it can play for people taking (and/or interruption) GLP-1 drugs. Exercise can be critical for maintaining muscle mass, which in turn supports metabolism and overall health. While science is still unfolding, we know that different types, tensions and exercise tumors will need further study to refine the recommendations specifically for people receiving Aoms. It is important to note that exercise has always played a central role in providing people to achieve or maintain a healthy weight both through energy spending and positively affecting body composition.
Stay active, whether one gets an AOM or not, has huge benefits.
Exercise reduces the risk chronic illnessprotects osteoporosisIt improves insulin sensitivityreinforces disposal; forward restful sleep and maintains the metabolism hum. In short, this remains one of the more effective, empowering and sustainable tools For long -term health at any stage of life.
Each time food intake is significantly reduced, energy levels can be affected. People in Aoms often have very low appetites, so it is important for exercise professionals to help ensure that customers eat enough to stay well and support their levels of activity.
Collaboration with a qualified obesity physician or an advanced practice provider (nurse or assistant physician) and a registered nutritionist can help customers ensure that they get proper nutrition and are ready for exercise while seeking improvements. This is especially important for people in every AOM, as these drugs can reduce appetite and many have side effects, making some people more difficult to get enough nutrients to stay strong and maintain muscles.
What role does muscle maintenance play in the weight loss process for women in Menopause using AOM and how can professionals practice professionals modify Their programs to support these efforts?
Muscle preservation is the key, whether one takes a GLP-1 drug or not. Strong muscles help balance, stability, bone health and metabolism, which support long -term weight management and overall well -being.
When people lose weight quickly, either through bariatric surgery, very low calorie diet (VLCDs), pharmacological interventions or a combination of these approaches, they will lose some muscle tissue along with fat tissue. The goal is to minimize muscle loss and keep the body strong.
Research suggests that the combination of exercise with AOM can help people maintain weight loss after discontinuation of medication compared to those who interrupt drugs without exercise. But there is still a lot to learn, and individual preferences, acceptance of activity and ability should always be taken into account when they constitute movement.
Do you want to dive deeper? See these CERTIFIED Articles: The connection between exercise and menopause and Menopause and Movement: Strengthening customers through support -based.
What should exercise professionals be alert if a customer interrupts their AOM? How can they adjust training or nutrition strategies to support any changes to their client’s weight?
New weight loss medicines, such as GLP-1s, can help people lose significant weight. However, in real use, the data shows that about half of people stop receiving GLP1s within the first year due to factors such as costs, side effects or other reasons. When people stop the drug, research shows that there is a high risk of weight regaining.
Exercise professionals can play a key role in providing customers to create sustainable habits that support long -term success. This includes regular movement, structured eating habits, hunger awareness and focus on dense nutrients, whole foods.
Whenever possible, work alongside other healthcare providers specializing in metabolic health and obesity can provide well -rounded support, helping customers to achieve either activated or outside these drugs.
![]() | To find out more about How to effectively support customers receiving Aoms and browse the evolving health and fitness landscape, check out A guide to support customers in anti -obesity drugs (worth 0.2 ACE CECS). In this course, you Explore the mechanisms of Aoms and their impact Body composition. You Also learn about relationships between exercise, behavior patterns and aomsas well as the wider social and economic impact of these drugs. |